NIH-funded research R01 grant

Finding hidden genetic causes of congenital heart disease in newborns

Official title: Identifying unrecognized genetic causes of congenital heart disease

Funded at Brigham and Women's Hospital · NIH-11323997 · Data updated 2026-11-12

A study to uncover genetic reasons behind congenital heart defects in babies by examining both coding and non-coding DNA to explain cases that are currently unexplained.

More Heart Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 1, 2024
Project endMarch 31, 2028
Funding year2026
Award (this year)$741,393
NIH project number5R01HL162356-03
Project IDNIH-11323997 on NIH RePORTER

Who could benefit from this research

Could help

Newborns and infants with congenital heart defects and their families who have DNA data available for analysis.

Less likely to help

Families without CHD or without access to genetic testing may not directly benefit.

What this research studies

The project will analyze DNA from babies with congenital heart defects to look for de novo and rare variants, including noncoding changes near heart-development genes. It will use high-throughput tests to see how these noncoding variants affect gene regulation in heart-related cells derived from induced pluripotent stem cells. When promising variants are found, researchers will edit them in their natural gene locations and use single-nucleus RNA sequencing to observe how gene activity and cell states change. The work aims to connect genetic variations to heart development outcomes, potentially leading to better diagnosis and understanding of CHD.

Why it matters

Potential benefit: If successful, this research could improve how we diagnose the genetic causes of CHD and inform personalized care for affected babies.

How similar studies have gone: Previous work has linked coding variants to CHD, and this project extends that with noncoding variants and functional assays.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Seidman, Christine E — Brigham and Women's Hospital
  • Study coordinator: Seidman, Christine E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.